CAM

Cormorant Asset Management Portfolio holdings

AUM $1.34B
This Quarter Return
+40.97%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$907M
AUM Growth
+$907M
Cap. Flow
+$30M
Cap. Flow %
3.31%
Top 10 Hldgs %
41.16%
Holding
94
New
10
Increased
12
Reduced
5
Closed
9

Top Buys

1
CLVS
Clovis Oncology, Inc.
CLVS
$23.4M
2
PTGX icon
Protagonist Therapeutics
PTGX
$16.9M
3
KA
Kineta, Inc. Common Stock
KA
$15.5M
4
MYOK
MyoKardia, Inc. Common Stock
MYOK
$13.8M
5
IVTY
Invuity, Inc
IVTY
$10.1M

Top Sells

1
TSRO
TESARO, Inc.
TSRO
$30.5M
2
NKTR icon
Nektar Therapeutics
NKTR
$28.8M
3
SAGE
Sage Therapeutics
SAGE
$22M
4
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$18.9M
5
NVAX icon
Novavax
NVAX
$11.8M

Sector Composition

1 Healthcare 91.67%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
GNVC
76
DELISTED
GenVec, Inc.
GNVC
$468K 0.05%
1,015,685
-174,965
-15% -$80.6K
NEOS
77
DELISTED
Neos Therapeutics, Inc
NEOS
$333K 0.04%
50,613
– –
PVCT
78
DELISTED
PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
$221K 0.02%
2,226,961
– –
ONSIW
79
DELISTED
Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
$199K 0.02%
416,666
– –
ADAP
80
Adaptimmune Therapeutics
ADAP
$13.9M
$178K 0.02%
25,307
– –
AGTC
81
DELISTED
Applied Genetic Technologies Corporation
AGTC
$169K 0.02%
17,321
– –
CLRB icon
82
Cellectar Biosciences
CLRB
$15.3M
$145K 0.02%
53,649
– –
PVCT.WS
83
DELISTED
PROVECTUS BIOPHARMACEUTICALS INC WTS (DE)
PVCT.WS
$114K 0.01%
2,200,000
– –
CLRBW
84
DELISTED
Cellectar Biosciences, Inc.
CLRBW
$13K ﹤0.01%
52,999
– –
RLYP
85
DELISTED
RELYPSA INC COM
RLYP
– –
-450,000
Closed -$8.33M
VTAE
86
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
– –
-1,754,795
Closed -$18.9M
TSRO
87
DELISTED
TESARO, Inc.
TSRO
– –
-362,875
Closed -$30.5M
SAGE
88
DELISTED
Sage Therapeutics
SAGE
– –
-730,000
Closed -$22M
AGIO icon
89
Agios Pharmaceuticals
AGIO
$2.36B
– –
-50,000
Closed -$2.1M
DVAX icon
90
Dynavax Technologies
DVAX
$1.19B
– –
-635,000
Closed -$9.26M
MCRB icon
91
Seres Therapeutics
MCRB
$162M
– –
-253,064
Closed -$7.35M
NKTR icon
92
Nektar Therapeutics
NKTR
$543M
– –
-2,022,879
Closed -$28.8M
NVAX icon
93
Novavax
NVAX
$1.2B
– –
-1,619,608
Closed -$11.8M
1 2 3
4